← Eichor
Study identifier: NCT07570264 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

LEXURE for Post-Stroke Aphasia

Condition: Aphasia  ·  Sponsor: Nunaps Inc

PhaseNA
Planned participants116
Who can joinAll sexes, 19 Years to no upper limit
Healthy volunteersYes

About this study

This study evaluates the efficacy of digital language rehabilitation using LEXURE for the treatment of post-stroke aphasia. Half of participants will receive structured language training using the LEXURE application, while the other half will receive workbook-based language training as an active comparator.

This description comes directly from the study's public registry record.

Talk to the study team

Suekyung Jung  ·  +82-2-488-6542  ·  skjung@nunaps.com

Always discuss trial participation with your own doctor first.

Locations (12)

Korea University Ansan HospitalAnsan, Gyeonggi-do, South KoreaNot Yet Recruiting
Inje University Busan Paik HospitaBusan, South KoreaRecruiting
Hallym University Chuncheon Sacred Heart HospitalChuncheon, South KoreaRecruiting
Kyungpook National University HospitalDaegu, South KoreaNot Yet Recruiting
Yeungnam University Medical CenterDaegu, South KoreaNot Yet Recruiting
Keimyung University Dongsan HospitalDaegu, South KoreaRecruiting
Chonnam National University HospitalGwangju, South KoreaRecruiting
Inje University Ilsan Paik HospitalIlsan, South KoreaRecruiting
Jeonbuk National University HospitalJeonju, South KoreaNot Yet Recruiting
Asan Medical CenterSeoul, South KoreaRecruiting
Konkuk University Medical CenterSeoul, South KoreaRecruiting
Ulsan University HospitalUlsan, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07570264